Table 2 Baseline characteristics between high CEE and low CEE groups
Variables | Low CEE (n = 12,967) | High CEE (n = 12,966) | p |
|---|---|---|---|
Age (years) | 63.7 ± 10.4 | 61.4 ± 10.2 |  < .01 |
Male (n, %) | 6392 (49.3) | 7069 (54.5) |  < .01 |
BMI (kg/m2) | 24.3 ± 6.2 | 25.9 ± 11.1 |  < .01 |
Current smoker (n, %) | 837 (6.5) | 998 (7.7) |  < .01 |
Alcohol drinking (n, %) | 973 (7.5) | 1146 (8.8) |  < .01 |
Systolic BP (mmHg) | 120.1 ± 10.3 | 120.9 ± 9.9 |  < .01 |
Diastolic BP (mmHg) | 74.0 ± 5.7 | 74.9 ± 5.4 |  < .01 |
Hypertension (n, %) | 7850 (60.5) | 8450 (65.2) |  < .01 |
Anti-hypertensive drug (n, %) | 6729 (52.2) | 7238 (55.8) |  < .01 |
Dyslipidemia (n, %) | 7628 (58.8) | 10,836 (83.6) |  < .01 |
Statin (n, %) | 5466 (42.2) | 5723 (44.1) | 0.01 |
TG-lowering drug (n, %) | 73 (0.6) | 703 (5.4) |  < .01 |
Chronic kidney disease (n, %) | 2645 (20.4) | 3043 (23.5) |  < .01 |
Insulin use (n, %) | 3534 (27.3) | 3250 (25.1) |  < .01 |
Antiplatelet drug (n, %) | 4758 (36.7) | 4673 (36.0) | 0.28 |
Anticoagulant (n, %) | 249 (1.9) | 223 (1.7) | 0.23 |
Glucose (mg/dL) | 134.4 ± 33.9 | 139.1 ± 35.2 |  < .01 |
HbA1c (%) | 7.0 ± 1.2 | 7.2 ± 1.2 |  < .01 |
Creatinine (mg/dL) | 1.22 ± 1.30 | 1.25 ± 1.23 | 0.12 |
hsCRP (mg/dL) | 3.3 ± 3.0 | 3.3 ± 2.9 | 0.87 |
Total cholesterol (mg/dL) | 164.1 ± 30.0 | 181.7 ± 31.6 |  < .01 |
LDL-cholesterol (mg/dL) | 96.2 ± 25.8 | 105.1 ± 28.4 |  < .01 |
HDL-cholesterol (mg/dL) | 50.2 ± 12.5 | 44.5 ± 10.0 |  < .01 |
Triglyceride (mg/dL) | 102.0 ± 23.8 | 219.4 ± 90.5 |  < .01 |
TG-CV (%) | 29.5 ± 14.4 | 37.9 ± 19.7 |  < .01 |
TG-CEE (arbitrary unit) | 3984.9 ± 667.8 | 7250.0 ± 2387.3 |  < .01 |
Number of TG measurement | 6.0 ± 3.9 | 6.5 ± 4.0 |  < .01 |
Interval between TG measurement (day) | 222.8 ± 131.8 | 202.2 ± 126.0 |  < .01 |